Related references
Note: Only part of the references are listed.Importance of the Genetic Diversity within the Mycobacterium tuberculosis Complex for the Development of Novel Antibiotics and Diagnostic Tests of Drug Resistance
Claudio U. Koeser et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Gene Sequencing for Routine Verification of Pyrazinamide Resistance in Mycobacterium tuberculosis: a Role for pncA but Not rpsA
David C. Alexander et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
Andreas H. Diacon et al.
LANCET (2012)
Two New Rapid SNP-Typing Methods for Classifying Mycobacterium tuberculosis Complex into the Main Phylogenetic Lineages
David Stucki et al.
PLOS ONE (2012)
Impact of fgd1 and ddn Diversity in Mycobacterium tuberculosis Complex on In Vitro Susceptibility to PA-824
Silke Feuerriegel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Clinical characteristics of the smooth tubercle bacilli 'Mycobacterium canettii' infection suggest the existence of an environmental reservoir
J. -L. Koeck et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
Wanliang Shi et al.
SCIENCE (2011)
Sequencing of the pncA gene in members of the Mycobacterium tuberculosis complex has important diagnostic applications:: Identification of a species-specific pncA mutation in Mycobacterium canettii and the reliable and rapid predictor of pyrazinamide resistance
Akos Somoskovi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Share Paper
